Delivery Order 36C25221D0063-36C25223N0403

Award Date 7/15/23
Potential Completion Date 7/14/26
Potential Value $1.9M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $51,900 firm fixed price delivery order to Boston Scientific Corporation for Yttrium-90 Therasphere radiopharmaceuticals. The period of performance extends through September 30, 2023. No set-aside provisions were applied to this contract action. As the prime contractor, Boston Scientific will provide brachytherapy products to treat cancer at VA medical facilities in the New...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a $189,100 firm fixed price delivery order to Boston Scientific Corporation for the procurement of yttrium-90 theraspheres. As the prime contractor, Boston Scientific will provide these radioactive microspheres used in interventional radiology procedures to treat inoperable liver tumors. The period of performance is from October 1, 2020 through September 30, 2021 at the place of...
Boston Scientific Corporation, doing business as Boston Scientific, was awarded a $313,200 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to provide Yttrium-90 TheraSphere radioactive microspheres. This delivery order was issued against the company's existing indefinite delivery contract with the VA worth up to $295 million over five years to supply surgical implants and related services. No set-aside...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded Boston Scientific Corporation a $228,000 firm fixed price delivery order for TheraSphere Y-90 radioactive microspheres. As the prime contractor, Boston Scientific will provide interventional radiology treatment services utilizing TheraSphere Y-90 microspheres for radioactive therapy. This delivery order was issued against the company's existing indefinite delivery contract with the VA...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a $171,000 purchase order to Boston Scientific Corporation for the delivery of Y-90 Theraspheres. As the prime contractor, Boston Scientific will provide radioactive microspheres used in interventional radiology procedures to treat cancer in the liver. The single award firm fixed price contract has a base period of performance from September 2023 through February 2024 for the medical...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 (VA - VHA) awarded a $266,000 Delivery Order contract to Boston Scientific Corporation, doing business as Boston Scientific, of Marlborough, Massachusetts. The firm fixed price contract is for the provision of Yttrium-90 Therasphere Radiopharmaceutical and runs from October 1, 2022 through July 14, 2026. The place of performance is Boston Scientific's facility in Marlborough, Massachusetts.
The U.S. Department of Veterans Affairs (VA) has awarded a sole-source, firm-fixed-price contract to Boston Scientific Corp for the supply of Y-90 TheraSphere doses and associated administration materials. The contract, valued at $777,740.00, covers an initial 2-year base period from October 1, 2022, to September 30, 2024, with an option to extend for an additional year through September 30, 2024. This contract is not set-aside. The Y-90 TheraSphere doses are used for the treatment of liver...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Boston Scientific Corp, a for-profit medical device manufacturer, to provide TheraSphere yttrium-90 glass microsphere radiotherapy treatments. The $230,050 contract has a completion date of September 30, 2022. No set-aside designation was used. The TheraSphere treatment involves infusing microscopic radioactive glass microspheres into the arteries feeding liver tumors to deliver high...
This is a federal contract award from the Veterans Integrated Service Network 12 (VISN 12), a division of the U.S. Department of Veterans Affairs (VA), to Boston Scientific Corporation, a global medical technology company. The contract is for the delivery of Y90 TheraSphere radiopharmaceutical, a specialized medical device used for the treatment of liver cancer. The contract has a ceiling value of $79,420.00 and is a firm fixed-price delivery order contract, with a period of performance...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VA - VHA VISN 16) awarded Boston Scientific Corporation a $18,000 purchase order to deliver Y-90 THERASPHERE doses. As the prime contractor, Boston Scientific will provide radioactive microspheres used in interventional radiology procedures to treat cancer in the liver. The firm fixed price order runs from October 2, 2023 through November 2, 2023 and will be carried out by Boston...
  • 36C25221D0063
    Indefinite Delivery Contract
  • 36C25221D0063-36C25223N0403
    Delivery Order

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 (VA-VHA) awarded a $1.93 million firm fixed price delivery order contract to Boston Scientific Corporation, doing business as Boston Scientific, to provide Yttrium-90 TheraSphere radiopharmaceuticals. The contract runs from July 15, 2023 through July 14, 2026 and will be performed in Marlborough, Massachusetts. Yttrium-90 TheraSphere is a brachytherapy treatment for inoperable liver cancer, delivering high doses of radiation directly to tumors while minimizing exposure to surrounding healthy tissue. This award will support the VA-VHA's efforts to provide state-of-the-art cancer care to veterans.

Generated 11/28/23, 12:57 PM